Pharmacogenetics and therapeutic drug monitoring in clinical practice

Genetic markers are ideal biomarkers, since they do notsuffer from reverse causation McMahon 2015

Review and meta-analysis of antidepressantpharmacogenetic findings in major depressive disorder. Kato 2008

The Promise of Psychiatric Pharmacogenomics Hamilton 2015

The potential impact of pharmacogenetic testing on medication adherence Haga 2013

The specific genetic variations that define variable phenotypes can be located on a Web site maintained by the Karolinska Institute (http://www.cypalleles.ki.se/). 


What is needed to incorporate pharmacogenetic testing into clinical practice de 2016

Pharmacogenomics and personalized medicine in neuropsychiatry McMahon 2012





Common Genetic Variation and Antidepressant Efficacy in Major Depressive Disorder: A Meta-Analysis of Three Genome-Wide Pharmacogenetic Studies Uher 2013

Clinical applications of CYP genotyping in psychiatry Kropp 2002 Spina 2014 Spina 2015


The combined effe